N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide

C27H33N5O4S — CID 10311603

IUPACN-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide
SMILESCOc1ccc(N2CCOCC2)c2sc(NC(=O)c3ccc(CN(C)C(=O)CN4CCCC4)cc3)nc12
InChIInChI=1S/C27H33N5O4S/c1-30(23(33)18-31-11-3-4-12-31)17-19-5-7-20(8-6-19)26(34)29-27-28-24-22(35-2)10-9-21(25(24)37-27)32-13-15-36-16-14-32/h5-10H,3-4,11-18H2,1-2H3,(H,28,29,34)
InChIKeyYLFWDYHFTRQZNJ-UHFFFAOYSA-N
MW523.66 g/mol
LogP3.45
Rot. Bonds8

About N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide

N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide (PubChem CID 10311603) has the molecular formula C27H33N5O4S and a molecular weight of 523.66 g/mol. Its IUPAC name is N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide.

Molecular Properties

Compound NameN-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide
PubChem CID10311603
Molecular FormulaC27H33N5O4S
Molecular Weight523.66 g/mol
Exact Mass523.23
IUPAC NameN-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide
SMILESCOc1ccc(N2CCOCC2)c2sc(NC(=O)c3ccc(CN(C)C(=O)CN4CCCC4)cc3)nc12
InChIInChI=1S/C27H33N5O4S/c1-30(23(33)18-31-11-3-4-12-31)17-19-5-7-20(8-6-19)26(34)29-27-28-24-22(35-2)10-9-21(25(24)37-27)32-13-15-36-16-14-32/h5-10H,3-4,11-18H2,1-2H3,(H,28,29,34)
InChIKeyYLFWDYHFTRQZNJ-UHFFFAOYSA-N
XLogP3.45
TPSA87.24 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500523.66
LogP ≤ 53.45
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_C(246)', 'substructure': 'N/A'}

Analyze N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide?
The IUPAC name of N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide (CID 10311603) is N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide.
What is the SMILES notation for N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide?
The canonical SMILES for N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide is COc1ccc(N2CCOCC2)c2sc(NC(=O)c3ccc(CN(C)C(=O)CN4CCCC4)cc3)nc12.
What is the InChIKey of N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide?
The InChIKey is YLFWDYHFTRQZNJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H33N5O4S/c1-30(23(33)18-31-11-3-4-12-31)17-19-5-7-20(8-6-19)26(34)29-27-28-24-22(35-2)10-9-21(25(24)37-27)32-13-15-36-16-14-32/h5-10H,3-4,11-18H2,1-2H3,(H,28,29,34).
What are the key properties of N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide?
N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide has a molecular weight of 523.66 g/mol, XLogP of 3.45, 8 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-[[methyl-(2-pyrrolidin-1-ylacetyl)amino]methyl]benzamide is sourced from PubChem (CID 10311603), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).